Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131207 · ClinicalTrials.gov registry record
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 139
- Enrollment target
NCT02131207 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 139 participants.
The verdict
NCT02131207 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. This diagnostic procedure may aid in identifying lesions in the prostate which may have cancer. The lesions can then be targeted during the prostate biopsy to improve the accuracy of identifying prostate cancer.
Interventions
- DEVICE magnetic resonance imaging
- PROCEDURE prostate biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2014-09-10 |
| Est. Completion | 2017-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131207
The ClinicalTrials.gov registry entry for NCT02131207 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT02131207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131207 about?
NCT02131207 is a clinical study titled "MRI Before Biopsy in Diagnosing Patients With Prostate Cancer". This pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. This diagnost...
What is the current status of trial NCT02131207?
This trial is currently terminated. The enrollment target is 139 participants. The study started on 2014-09-10. Estimated completion is 2017-12-08.
What interventions are being tested in trial NCT02131207?
The interventions under investigation include: magnetic resonance imaging (DEVICE), prostate biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02131207?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.